MiNA Therapeutics

Andrew Bentley

QA Manager
MiNA Therapeutics

Andrew joined in 2018 to drive Quality and Risk Management efforts at MiNA. Andrew has over 30 years experience in Quality and Risk Management to GxP in biopharmaceuticals and medical devices including at inVentiv Health Clinical, INC Research, Covance, Hertford Medical and Boots-Celltech. Andrew has a BSc in Biochemistry and DPhil in Neuroendocrinology both from University of Sussex, and undertook postdoctoral research at Oxford University.

Andrew Bentley’s Session(s)

— 9:45 am EST
Improving Quality by Identifying Common Issues with TMF Process and System

Copyright © 2021 Lincoln Health Network | Terms and Conditions | Privacy Policy